Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.
Dan-Petach Tikva District, Clalit Health Services, 1 Rishon Lezion St., Petach Tikva, 4972339, Israel.
Eur J Pediatr. 2023 Jul;182(7):3211-3216. doi: 10.1007/s00431-023-04995-1. Epub 2023 May 2.
Benign transient hyperphosphatasemia is a condition characterized by greatly increased serum alkaline phosphatase (ALP) without laboratory or clinical evidence of underlying bone or liver disease. It is usually identified incidentally during routine blood testing. We describe the demographic and clinical characteristics of benign transient hyperphosphatasemia in a cohort of healthy infants and children. We performed a retrospective review of electronic medical records on all children aged 1 day to 18 years with a diagnosis of benign transient hyperphosphatasemia, who were registered at 3 central districts in Israel from January 1, 2000, to December 31, 2020. The demographic and clinical characteristics were retrieved from the medical files. The study group comprised 382 infants and children aged from 2 months to 14 years who had serum ALP > 1000 U/L (mean 2557 U/L, range 1002-14,589 U/L). The majority of participants (87%) were aged up to 24 months (median age 14 months, IQR 10-18 months). Fifty-four percent of the study participants were male. In many patients, there was a history of recent fever, gastroenteritis or diarrhea, acute otitis media, and viral infection. A seasonal peak was observed in autumn-early winter, but this may be a detection bias.
Benign transient hyperphosphatasemia seems to be a disorder described among otherwise healthy infants and children, which resolves spontaneously. Other known causes of markedly elevated serum ALP should be excluded, especially bone and liver disease. Higher awareness and recognition of this benign condition are important in order to avoid unnecessary tests and parental anxiety.
• Benign transient hyperphosphatasemia is a benign condition characterized by greatly increased serum alkaline phosphatase without laboratory or clinical evidence of underlying bone or liver disease, which usually resolves spontaneously, with no intervention.
• In the case of an incidental finding of high serum alkaline phosphatase in an otherwise healthy infant or child with no other clinical or laboratory suspicion of bone or liver disease, we recommend repeating the alkaline phosphatase level within a few months in order to confirm the resolution of this condition. • When benign transient hyperphosphatasemia is suspected, a "wait and see" approach is optimal in order to avoid unnecessary investigations and parental anxiety.
描述在一个健康的婴儿和儿童队列中良性一过性高磷酸血症的特征。
我们对 2000 年 1 月 1 日至 2020 年 12 月 31 日期间在以色列 3 个中心区登记的所有年龄在 1 天至 18 岁之间、诊断为良性一过性高磷酸血症的儿童的电子病历进行了回顾性分析。从病历中提取人口统计学和临床特征。
研究组包括 382 名年龄在 2 个月至 14 岁之间的婴儿和儿童,血清碱性磷酸酶(ALP)>1000U/L(平均 2557U/L,范围 1002-14589U/L)。大多数参与者(87%)年龄在 24 个月以下(中位年龄 14 个月,IQR 10-18 个月)。54%的研究参与者为男性。许多患者有近期发热、胃肠炎或腹泻、急性中耳炎和病毒感染史。秋季至初冬观察到季节性高峰,但这可能是检测偏差。
良性一过性高磷酸血症似乎是一种发生在其他健康婴儿和儿童中的疾病,可自发缓解。应排除其他已知的明显升高血清 ALP 的原因,尤其是骨骼和肝脏疾病。提高对这种良性疾病的认识和认识非常重要,以避免不必要的检查和父母的焦虑。
良性一过性高磷酸血症是一种良性疾病,其特征是血清碱性磷酸酶显著升高,无骨骼或肝脏疾病的实验室或临床证据,通常可自发缓解,无需干预。
在没有其他骨骼或肝脏疾病的临床或实验室怀疑的情况下,偶然发现高血清碱性磷酸酶在健康婴儿或儿童中,建议在几个月内重复碱性磷酸酶水平以确认该情况的缓解。怀疑良性一过性高磷酸血症时,“等待观察”的方法是最佳的,以避免不必要的检查和父母的焦虑。